Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II Study of Sagopilone + carboplatin + bevacizumab in first-line treatment of advanced non-squamous NSCLC
2008-001494-15Phase 2Terminated
- Sponsor
- Bayer
- Start
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of sagopilone in Non-small cell lung cancer (NS-NSCLC), sponsored by Bayer. Primary endpoint: Phase I primary endpoint. Started May 2008; status: terminated.
02
Drugs
sagopilone
03
Conditions
Non-small cell lung cancer (NS-NSCLC)
Beyond the preview
Go deeper on 2008-001494-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001494-15.